Englander Institute for Precision Medicine
New tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells. Credit: Christian Stolte

An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial...

EIPM Director Olivier Elemento, Ph.D.

June 2024 EIPM Director's Memo


Dear Members of the Englander Institute,

Thank you all for a very productive past six weeks!

On May 6th I was honored to led a delegation from the Indian Council of Medical Research on a tour of our labs and introduce them to staff. Thanks to our colleagues who...

science paper graphic

Dear Members of the Englander Institute,

Thank you all for a very productive April!

Please join me in congratulating our colleague Dr.Niroshana Anandasabapathy on earning a new R01 award from the NIH! The title of her award is ...